UroGen Pharma Ltd. (URGN)

AI Score

Unlock

10.07

0.41 (4.24%)

At close: Apr 09, 2025, 3:59 PM

9.60

-4.71%

Pre-market: Apr 10, 2025, 08:00 AM EDT

Dividends

No dividend history available for UroGen Pharma Ltd..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

URGN News

1 month ago · UroGen Pharma Ltd. (URGN) Q4 2024 Earnings Call Transcript - seekingalpha.com
1 month ago · Urogen Pharma (URGN) Reports Q4 Loss, Lags Revenue Estimates - zacks.com
1 month ago · UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - businesswire.com
1 month ago · UroGen Pharma to Report Fourth Quarter and Full-Year 2024 Financial Results on Monday, March 10, 2025 - businesswire.com
1 month ago · UroGen Announces Results from Subgroup Analyses of the Pivotal ENVISION Trial Evaluating Impact of Baseline Tumor Burden and Focality on Response to UGN-102 - businesswire.com
2 months ago · UroGen: Upcoming PDUFA, Some Concerns Remain - seekingalpha.com
2 months ago · UroGen Pharma to Present at Upcoming Investor Conferences - businesswire.com